Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Yalcin, ŞUAYİB; Oksuzoglu, B; Tekuzman, G; Engin, H; Celik, İSMAİL; Turker, A; Barista, İBRAHİM; Gullu, İBRAHİM; Guler, N; Altundag, K; Ozisik, Y; Kars, A

doi:10.1093/jjco/hyg111

Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., ...More

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, vol.33, no.11, pp.580-583, 2003 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 33 Issue: 11
Publication Date: 2003
Doi Number: 10.1093/jjco/hyg111
Journal Name: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.580-583
Hacettepe University Affiliated: Yes

Abstract

Objective: In this study, we evaluated the efficacy and tolerability of biweekly irinotecan (CPT-11) plus 5-fluorouracil (5-FU) and folinic acid (FA) regimen (IFL) in patients with advanced stage colorectal cancer.